These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. P-selectin gene haplotypes modulate soluble P-selectin concentrations and contribute to the risk of venous thromboembolism. Ay C; Jungbauer LV; Kaider A; Koder S; Panzer S; Pabinger I; Mannhalter C Thromb Haemost; 2008 May; 99(5):899-904. PubMed ID: 18449419 [TBL] [Abstract][Full Text] [Related]
23. Statins, inflammation and deep vein thrombosis: a systematic review. Rodriguez AL; Wojcik BM; Wrobleski SK; Myers DD; Wakefield TW; Diaz JA J Thromb Thrombolysis; 2012 May; 33(4):371-82. PubMed ID: 22278047 [TBL] [Abstract][Full Text] [Related]
24. Effects of a 1-year supplementation with cholecalciferol on interleukin-6, tumor necrosis factor-alpha and insulin resistance in overweight and obese subjects. Beilfuss J; Berg V; Sneve M; Jorde R; Kamycheva E Cytokine; 2012 Dec; 60(3):870-4. PubMed ID: 22925537 [TBL] [Abstract][Full Text] [Related]
25. The role of serum bilirubin levels in determining venous thromboembolism. Duman H; Özyurt S; Erdoğan T; Kara BY; Durakoğlugil ME J Vasc Surg Venous Lymphat Disord; 2019 Sep; 7(5):635-639. PubMed ID: 30922986 [TBL] [Abstract][Full Text] [Related]
26. Anticoagulation strategies for venous thromboembolism: moving towards a personalised approach. Black SA; Cohen AT Thromb Haemost; 2015 Oct; 114(4):660-9. PubMed ID: 26084864 [TBL] [Abstract][Full Text] [Related]
27. Effect of vitamin D3 supplementation and influence of BsmI polymorphism of the VDR gene of the inflammatory profile and oxidative stress in elderly women with vitamin D insufficiency: Vitamin D3 megadose reduces inflammatory markers. de Medeiros Cavalcante IG; Silva AS; Costa MJ; Persuhn DC; Issa CT; de Luna Freire TL; da Conceição Rodrigues Gonçalves M Exp Gerontol; 2015 Jun; 66():10-6. PubMed ID: 25827670 [TBL] [Abstract][Full Text] [Related]
28. High Dose Supplementation of Vitamin D Affects Measures of Systemic Inflammation: Reductions in High Sensitivity C-Reactive Protein Level and Neutrophil to Lymphocyte Ratio (NLR) Distribution. Tabatabaeizadeh SA; Avan A; Bahrami A; Khodashenas E; Esmaeili H; Ferns GA; Abdizadeh MF; Ghayour-Mobarhan M J Cell Biochem; 2017 Dec; 118(12):4317-4322. PubMed ID: 28425575 [TBL] [Abstract][Full Text] [Related]
29. Apixaban for the Treatment of Japanese Subjects With Acute Venous Thromboembolism (AMPLIFY-J Study). Nakamura M; Nishikawa M; Komuro I; Kitajima I; Uetsuka Y; Yamagami T; Minamiguchi H; Yoshimatsu R; Tanabe K; Matsuoka N; Kanmuri K; Ogawa H Circ J; 2015; 79(6):1230-6. PubMed ID: 25912695 [TBL] [Abstract][Full Text] [Related]
30. The risk of recurrent venous thromboembolism in patients with unprovoked symptomatic deep vein thrombosis and asymptomatic pulmonary embolism. Jiménez D; Díaz G; Marín E; Vidal R; Sueiro A; Yusen RD Thromb Haemost; 2006 Mar; 95(3):562-6. PubMed ID: 16525588 [TBL] [Abstract][Full Text] [Related]
31. Postoperative prophylaxis of venous thromboembolism (VTE) in patients undergoing high ligation and stripping of the great saphenous vein (GSV). Wang H; Sun Z; Jiang W; Zhang Y; Li X; Wu Y Vasc Med; 2015 Apr; 20(2):117-21. PubMed ID: 25601917 [TBL] [Abstract][Full Text] [Related]
32. Inflammatory Biomarkers in the Short-Term Prognosis of Venous Thromboembolism: A Narrative Review. Galeano-Valle F; Ordieres-Ortega L; Oblitas CM; Del-Toro-Cervera J; Alvarez-Sala-Walther L; Demelo-Rodríguez P Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807848 [TBL] [Abstract][Full Text] [Related]
33. D-Dimer Levels and Vitamin K Antagonist Therapy in Deep Vein Thrombosis of the Legs. Park JK; Koo do H; Yoon DH; Lee JN Ann Vasc Surg; 2016 Jul; 34():119-34. PubMed ID: 27177705 [TBL] [Abstract][Full Text] [Related]
34. The use of rivaroxaban for short- and long-term treatment of venous thromboembolism. Cohen AT; Dobromirski M Thromb Haemost; 2012 Jun; 107(6):1035-43. PubMed ID: 22371186 [TBL] [Abstract][Full Text] [Related]
35. C-reactive protein 3' UTR +1444C>T polymorphism in patients with spontaneous venous thromboembolism. Vormittag R; Funk M; Mannhalter C; Schönauer V; Vukovich T; Minar E; Bialonczyk C; Hirschl M; Pabinger I Atherosclerosis; 2006 Oct; 188(2):406-11. PubMed ID: 16352308 [TBL] [Abstract][Full Text] [Related]
36. High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). Ay C; Simanek R; Vormittag R; Dunkler D; Alguel G; Koder S; Kornek G; Marosi C; Wagner O; Zielinski C; Pabinger I Blood; 2008 Oct; 112(7):2703-8. PubMed ID: 18539899 [TBL] [Abstract][Full Text] [Related]
37. Residual venous obstruction, alone and in combination with D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study. Cosmi B; Legnani C; Iorio A; Pengo V; Ghirarduzzi A; Testa S; Poli D; Tripodi A; Palareti G; Eur J Vasc Endovasc Surg; 2010 Mar; 39(3):356-65. PubMed ID: 20034816 [TBL] [Abstract][Full Text] [Related]
38. Circulating P-selectin and the risk of recurrent venous thromboembolism. Kyrle PA; Hron G; Eichinger S; Wagner O Thromb Haemost; 2007 Jun; 97(6):880-3. PubMed ID: 17549288 [TBL] [Abstract][Full Text] [Related]
39. High concentrations of soluble P-selectin are associated with risk of venous thromboembolism and the P-selectin Thr715 variant. Ay C; Jungbauer LV; Sailer T; Tengler T; Koder S; Kaider A; Panzer S; Quehenberger P; Pabinger I; Mannhalter C Clin Chem; 2007 Jul; 53(7):1235-43. PubMed ID: 17510305 [TBL] [Abstract][Full Text] [Related]